# AWS vs. Google Cloud vs. Azure for Genomics: A Comparison The short answer is that all three platforms can run the same genomics pipelines well, and the real difference between AWS, Google Cloud, and Azure for genomics lies in ecosystem maturity, pricing mechanics, and where each provider fits an organization's broader infrastructure, not in raw ability to execute a FASTQ-to-VCF workflow. A useful rule of thumb is this: choose AWS when you want the deepest genomics ecosystem and the most mature spot pricing market, choose Google Cloud when your priority is analysis-heavy workloads, BigQuery-driven exploration of variant data, or a simpler pricing surface, and choose Azure when your institution is already a Microsoft shop with enterprise agreements, Active Directory, and compliance obligations that Azure handles natively. This guide walks through each platform on its own terms, then compares them on the criteria that actually decide cloud bioinformatics projects: compute performance, object storage and data transfer, workflow orchestration, cost models, machine learning services, security, and multi-cloud portability. The goal is that by the end you can answer the "AWS or Google Cloud" question for your own lab rather than in the abstract. ## What Cloud Bioinformatics Actually Runs ![Three-step flow showing primary, secondary and tertiary genomics analysis and what each stage stresses in the cloud.](/article-images/illustrations/aws-vs-google-cloud-vs-azure-for-genomics-genomics-stages.webp) Before comparing providers, define the workload. Genomics computing splits into three stages, and each stresses the cloud differently. **Primary analysis** converts raw instrument output into aligned data. For sequencing, that means BCL conversion and demultiplexing at the instrument or in the cloud, followed by alignment with tools such as BWA-MEM2 or DRAGEN. These jobs are input/output heavy and benefit from fast local scratch storage. **Secondary analysis** takes aligned reads (BAM or CRAM files) through processing such as marking duplicates, base quality recalibration, and variant calling with tools like GATK HaplotypeCaller or DeepVariant. These jobs parallelize well across thousands of short-lived tasks, which is why spot or preemptible virtual machines matter so much in genomics. A single 30x whole-genome sample generates roughly 100 GB of BAM data and thousands of scatter tasks in a GATK pipeline. **Tertiary analysis** interprets variants, annotates them against resources such as those maintained by NCBI and EMBL-EBI, joins them with clinical or phenotype data, and increasingly applies machine learning. This stage is often more database and analytics shaped, which favors the data warehouse products of each cloud. All three stages fit a common cloud pattern: object storage holds the data, an orchestrator (Nextflow, WDL with Cromwell, or Snakemake) launches containerized tasks onto autoscaling compute, and results land back in object storage. General comparisons of the three providers consistently evaluate this same compute, storage, and performance triangle, and find that the platforms differ more in service packaging and billing than in fundamental capability [1]. ## Side-by-Side Comparison for Genomics Workloads The table below is the core of this comparison. Service names change over time, so treat this as a structural snapshot rather than a catalog. | Criterion | AWS | Google Cloud | Azure | |--|--|--|--| | Object storage | Amazon S3 | Cloud Storage | Azure Blob Storage | | Batch compute | EC2 autoscaling, AWS Batch | Compute Engine, Google Batch | Virtual Machines, Azure Batch | | Interruptible compute | Spot Instances | Spot and Preemptible VMs | Spot VMs | | Managed genomics workflow service | Deep ecosystem, including batch-oriented services and genomics-focused tooling | Life sciences tooling built around Batch and Dataflow | Managed genomics offering has been de-emphasized, teams typically use Azure Batch | | Workflow engine compatibility | Nextflow, Cromwell/WDL, Snakemake, Toil | Nextflow, Cromwell/WDL, Snakemake | Nextflow, Cromwell/WDL, Snakemake | | Data warehouse for variant and phenotype data | Redshift, Athena | BigQuery | Synapse Analytics | | ML platform | SageMaker | Vertex AI | Azure Machine Learning | | Serverless | Lambda | Cloud Functions | Azure Functions | | Enterprise integration angle | Broadest service catalog, largest ecosystem | Strong data and analytics stack, AI-optimized infrastructure | Deep Microsoft enterprise integration, compliance tooling | | Pricing levers | On-demand, Reserved/Savings Plans, Spot | On-demand, committed use discounts, spot | Pay-as-you-go, Reserved Instances, Spot | The structural similarity is the headline. Any pipeline that runs in a container can run on any of these clouds, and the deciding factors are operational. ## AWS for Genomics AWS is the oldest and largest of the three providers, and its genomics ecosystem reflects that head start. The standard comparison literature describes AWS as having the broadest and most mature service catalog, an advantage that extends to genomics-specific tooling, reference datasets, and community workflow repositories [1][2]. ### Compute and scaling on AWS A typical AWS genomics architecture uses S3 for FASTQ, BAM, and CRAM files, an orchestrator such as Nextflow or Cromwell running on a small head node or in a container, and AWS Batch to provision EC2 instances per task. AWS Batch handles the queueing and instance lifecycle so that a 10,000-task scatter, common in joint genotyping or RNA-seq quantification, can fan out across hundreds of spot instances and collapse back to zero when done. Spot Instances, which AWS sells as unused capacity at steep discounts, are the workhorse of cloud genomics economics. Interrupted tasks are retried by the orchestrator, which is exactly the fault-tolerant pattern Nextflow and Cromwell were built for. Independent work on pricing models across the three clouds emphasizes that spot pricing is one of the most significant cost levers available, and that choosing the right pricing model per workload is a major determinant of total spend [3]. ### Storage and data movement on AWS S3 is the de facto standard for genomics object storage, and an enormous amount of public reference data, from 1000 Genomes to dbGaP-accessible cohorts, already lives there. This network effect matters. If your collaborators, consortia, or data providers keep data in S3, co-locating your compute there avoids repeated egress and transfer cost, which is often a larger line item than compute itself in genomics. ### The AWS genomics ecosystem The AWS genomics ecosystem includes prebuilt pipeline services, genomics-focused AMIs, open-source projects, and a large community of published Nextflow and WDL pipelines tested against AWS first. Comparative studies of machine learning services describe AWS's SageMaker as part of an ecosystem characterized by maturity and flexibility [4], and SageMaker is a natural fit for the tertiary analysis stage, from polygenic risk score modeling to deep learning on medical images. AWS Lambda, the serverless option, is commonly used for file-triggered glue logic in genomics pipelines, such as validating an uploaded BCL directory or launching a workflow when a FASTQ lands in a bucket. ## Google Cloud for Genomics Google Cloud entered genomics early and built its offering around its strengths in data analytics and AI infrastructure. ### Compute and analytics on Google Cloud Compute Engine provides the same class of virtual machines as the competitors, and Google Batch handles the fan-out pattern for pipeline tasks. Where Google Cloud differentiates is in the analytics layer. BigQuery is a serverless columnar data warehouse that has become a popular destination for variant tables in cloud bioinformatics. Loading variant call format data into BigQuery, either directly or through BigQuery-specific genomics tooling, lets teams run cohort-scale queries with SQL instead of standing up clusters. For a study asking questions like "how many rare loss-of-function variants in gene X appear across 50,000 genomes," this is a fundamentally better interface than shell scripts over VCF files. Independent comparisons of machine learning platforms repeatedly find that Google Cloud performs strongly for AI-optimized workloads, reflecting its investments in accelerators and ML infrastructure [4]. For genomics teams doing deep learning on imaging or sequence data, this matters. ### Pricing and operations on Google Cloud Google Cloud's pricing surface is often described as simpler, with sustained-use discounts applied automatically rather than requiring commitment planning. A comparative analysis of pricing structures across the three providers examines on-demand, reserved, and spot schemes on each platform and concludes that cost optimization depends more on matching the pricing model to the workload than on any provider having universally cheaper list prices [3]. In practice, that means a genomics group with steady baseline demand commits a portion of capacity and runs bursty scatter tasks on spot, and can execute that strategy on any of the three clouds. Google Cloud also provides managed data engineering components, and broader analysis of cloud data engineering describes how managed services and serverless constructs across the three providers let teams build pipeline frameworks without maintaining physical servers [5]. For genomics, that translates into ingestion pipelines that move sequencing data from instruments or transfer services into cloud storage with minimal operational overhead. ## Azure for Genomics Azure is frequently discounted in genomics conversations, and that discount is sometimes warranted for pure research sequencing. But dismissing it ignores why many clinical genomics and hospital-affiliated groups end up there. ### Enterprise integration is Azure's center of gravity Comparative studies consistently find that Azure excels in enterprise integration and compliance services relative to the other two clouds. For a hospital system or diagnostic laboratory already running Active Directory, Microsoft 365, and Microsoft-based data warehousing, Azure removes an entire layer of identity and access management work. Genomics data is regulated data in most clinical contexts, and the ability to federate existing enterprise identities, apply established governance tooling, and keep data within an organization's existing compliance perimeter has real operational value. Research on governed AI deployments, which compares all three providers through a governance-first lens, argues that strategic value now depends less on provider choice and more on an organization's ability to operationalize MLOps, confidentiality, and trustworthy analytics under emerging governance regimes such as the EU AI Act and the NIST AI Risk Management Framework [6]. For clinical genomics groups building decision-support models, that framing applies directly. ### Compute and pipelines on Azure Azure Batch supports the same containerized, autoscaling task pattern used elsewhere, and Nextflow and Cromwell both run on Azure. A dedicated managed Microsoft Genomics service existed for several years but has been de-emphasized, so most Azure genomics today is assembled from Batch, Virtual Machine Scale Sets, and Azure HPC offerings rather than a turnkey genomics product. This is a genuine difference between the platforms. AWS and Google both maintain more genomics-specific service surfaces, while Azure expects you to build more yourself in exchange for tighter enterprise fit. A benchmarking study of compute-optimized instances across the three providers, using high-performance computing benchmarks including HPCC and HPCG, found that the optimal cloud solution is application-specific and varies with workload characteristics [7]. Applied to genomics, that means the right Azure instance family for your alignment step may differ from the right choice for variant calling, and benchmarking your actual pipeline beats reading list specifications. ### Azure's balanced middle ground An evaluation of cloud platforms for high-volume, latency-sensitive workloads found that Azure delivered stable performance and balanced cost, suited to medium-scale applications, while AWS delivered the best scalability and speed at a higher cost [8]. Although that study examined a real-time perception workload rather than genomics, the pattern is one genomics teams should recognize: Azure tends to sit between AWS and Google Cloud on both performance ceiling and price, which suits groups whose sequencing volume is moderate and predictable rather than spiky and massive. ## Head-to-Head on the Criteria That Decide Real Choices ### Compute performance Benchmarking studies that run identical workloads on identical instance types across the three clouds generally find performance differences too small and workload-dependent to drive platform selection. One study benchmarked all three providers in identical Ubuntu virtual environments using the Phoronix Test Suite, evaluating Apache, Dbench, and RAM speed benchmarks, and framed the comparison around equivalent environments rather than a single winner. Another HPC-focused study reached the same conclusion from the opposite direction, finding that the best platform depends on the workload's characteristics. The practical takeaway for genomics is to stop asking which cloud is "faster" in general and start benchmarking your own pipeline. Run your BWA-MEM2 alignment and GATK HaplotypeCaller steps on two or three candidate instance families on each cloud, measure wall time and cost per sample, and let those numbers decide. A day of benchmarking is worth more than any published comparison. ### Storage, egress, and data gravity Data gravity is the most underweighted factor in cloud selection for genomics. Sequencing data is large, and once a few hundred terabytes live in one cloud's object storage, moving it repeatedly is expensive and slow. Egress fees differ by provider and destination, and published pricing comparisons note that comparing effective costs across clouds is genuinely difficult because of these structural differences [3]. The decision rule is simple. Put compute where the data already is, or where the largest incoming stream will be. If your sequencing core delivers to S3, start on AWS even if you prefer another provider's analytics stack. Public reference datasets also show gravity, and a large fraction of public genomics data is hosted in AWS S3, which is one reason AWS genomics adoption is self-reinforcing. ### Cost model and optimization All three providers sell on-demand, committed-use, and interruptible capacity. The differences are in mechanics and defaults. A comparative study of resource management and cost efficiency across the three platforms examined pricing structures, auto-scaling, load balancing, and provisioning, and concluded that the right choice depends on workload profile and budget constraints rather than a universal winner [9]. Research on machine learning workloads found that applying cost optimization strategies across these platforms reduced costs by approximately 15 to 67 percent, but required deliberate selection of pricing models and attention to hidden fees [4]. For genomics specifically, the cost levers that matter are: 1. **Spot or preemptible capacity for scatter tasks.** Variant calling, read processing, and per-sample steps are fault-tolerant and interruptible. This is usually the single largest saving. 2. **Committed or reserved capacity for baseline load.** Orchestrator nodes, databases, and always-on services should sit on commitments. 3. **Storage class tiering.** BAM and CRAM files age quickly. Moving older runs to infrequent-access or archive tiers saves substantially, and lifecycle policies automate it. 4. **Data transfer discipline.** Keep intermediate files in the same region as compute, delete scratch data on completion, and minimize cross-cloud movement. A study of cross-provider cost efficiency emphasizes that cost optimization features and resource management techniques, not sticker prices, determine real outcomes [9]. That matches what genomics teams see in practice, where two groups on the same cloud can differ by an order of magnitude in cost per genome based on pipeline hygiene. ### Workflow orchestration Nextflow, WDL with Cromwell, and Snakemake run natively on all three clouds, with official or well-maintained plugins for AWS Batch, Google Batch/Life Sciences execution, and Azure Batch. This is the strongest argument against agonizing over the platform choice. Your pipeline code is portable. The open-source genomics workflow community, including major public pipeline collections, supports all three backends. Serverless functions complement workflows for glue logic, and a comparative security analysis of AWS Lambda, Azure Functions, and Google Cloud Functions evaluated authentication mechanisms, encryption practices, and compliance certifications across the three, finding all three viable with configuration differences rather than categorical differences [10]. If your pipeline uses serverless triggers, review each provider's configuration guides rather than assuming parity out of the box. ### Machine learning and tertiary analysis The three managed ML platforms map cleanly to each other: SageMaker on AWS, Vertex AI on Google Cloud, Azure Machine Learning on Azure. A review of AI and machine learning services across the providers describes each platform's offerings, including SageMaker on AWS, Vertex AI and AutoML on Google Cloud, and Azure Cognitive Services and integration tooling, all serving image recognition, predictive analytics, and natural language processing use cases [11]. A separate multi-cloud ML framework study similarly incorporates SageMaker, Azure Machine Learning, and Vertex AI as the standard distributed training surfaces on each cloud [12]. For genomics, the ML-relevant stages are variant quality scoring, phenotype prediction, image analysis in digital pathology, and sequence-based deep learning. The comparative MLaaS literature finds AWS strongest in ecosystem maturity and flexibility, Google Cloud strongest for AI-optimized workloads, and Azure strongest in enterprise integration and compliance [4]. Match that to your constraint: if ML is your bottleneck and your team is ML-native, Google Cloud's infrastructure bias helps. If ML models must live inside a governed enterprise environment, Azure's compliance profile helps. ### Security and compliance Genomics data is identifiable, sensitive, and long-lived. All three providers hold major compliance certifications and offer encryption at rest and in transit, and none is categorically more secure. A cross-cloud study of vulnerability landscapes noted that multi-cloud adoption creates genuine security management challenges because each platform exposes different vulnerability profiles and tooling [13]. If you operate on more than one cloud, budget for security operations across both. What differs is the fit with your institution. Azure's identity model aligns with Microsoft-based enterprises [4][14]. AWS has the longest track record with NIH-controlled-access data and regulated research workloads. Google Cloud offers strong defaults with less configuration. The right answer follows your organization's existing security operations capability, because a platform your security team knows beats a marginally stronger platform they must learn. ### Sustainability Genomics compute is energy intensive at scale, and sustainability now appears in grant applications and institutional planning. A comparative analysis of sustainability initiatives and carbon footprints across AWS, Azure, and Google Cloud assessed each provider's measures to mitigate environmental effects and emphasized combining renewable energy sourcing with AI-driven efficiency measures [15]. All three publish sustainability data and offer region selection with different energy profiles. If sustainability reporting matters to your institution, compare published regional carbon data for the specific regions you would actually use, since averages hide large regional variation. ### Multi-cloud portability Many genomics organizations end up multi-cloud by accident: a consortium delivers data in one cloud, a collaborator analyzes in another, and the institution has an enterprise agreement with a third. Research on multi-cloud interoperability finds that container-based workload portability and standardized identity federation are the most mature and broadly supported interoperability mechanisms across all three providers [14]. A related study of multi-cloud business continuity strategies highlights that proprietary interfaces and divergent API architectures are the main barriers to integration, proposing structured frameworks to address them [16]. Translated to genomics practice: keep your pipeline in containers, keep your orchestration tool-agnostic, and store data in open formats (CRAM rather than proprietary alignment formats, BCF or text VCF, Parquet for derived tables). Then moving a pipeline between clouds is an infrastructure task measured in days, not a rewrite measured in months. ## Worked Scenarios ### Scenario 1: A five-person academic lab sequencing 50 genomes per month Volume is low and bursty. The dominant costs are a small number of compute-hours and storage growth. The team knows Nextflow. There is no institutional cloud agreement. Recommendation pattern: AWS or Google Cloud, decided by where their public data and collaborators sit. At this scale, the price differences between clouds are smaller than the cost of one month of unmanaged storage growth. Turn on spot instances for scatter tasks, set lifecycle rules to tier CRAM files to infrequent access after 90 days, and use a managed ML platform only if tertiary analysis actually needs it. A free-tier or low-cost sandbox on any cloud suffices for learning, in the same way that one comparative study found a low-cost Google option served as an effective starting point with limitations in scale [8]. ### Scenario 2: A production genomics center processing thousands of genomes monthly Volume is high and sustained, with bursty scatter phases. Cost per genome is a tracked metric. Data arrives continuously. The team has dedicated bioinformatics engineering staff. Recommendation pattern: AWS or Google Cloud, chosen by data gravity and benchmarking. At this scale, spot pricing mechanics, committed-use discounts, and pipeline efficiency dominate the cost model, and the literature on cost optimization across these platforms shows savings of roughly 15 to 67 percent from deliberate pricing model selection [4]. Benchmark candidate instance families against the real pipeline. Invest in storage tiering aggressively, since storage often approaches or exceeds compute cost at this volume. The managed data engineering patterns described across the three clouds, combining serverless ingestion with managed processing, are the operational template [5]. ### Scenario 3: A clinical genomics laboratory inside a hospital system Data is regulated. Identity management is centralized. The institution has a Microsoft enterprise agreement and an established compliance program. Sequencing volume is moderate. Recommendation pattern: Azure, unless a hard technical blocker exists. The comparative literature identifies Azure's enterprise integration and compliance services as its distinctive strength [4], and governance-focused analysis argues that operationalizing MLOps and trustworthy analytics matters more than provider selection for regulated deployments [6]. Running clinical variant interpretation infrastructure inside the institution's existing identity, audit, and compliance perimeter reduces risk and administrative burden in ways that list-price comparisons do not capture. Azure Batch supports the required pipeline patterns, and Azure Machine Learning covers governed model deployment for tertiary analysis. ### Scenario 4: A consortium or multi-institution collaboration Multiple institutions, multiple existing cloud footprints, shared reference data, and grant-driven budgets. Recommendation pattern: design for multi-cloud from day one, or explicitly standardize on one provider and require it. The middle path is the expensive one. If multi-cloud is mandatory, lean on containers for portability and federated identity for access control, the two mechanisms the interoperability literature identifies as most mature across AWS, Azure, and Google Cloud [14][16]. Publish data with cloud-neutral access patterns so no single cloud's egress pricing becomes a consortium tax. ## When to Use AWS, and When Not To ![Decision path asking about Microsoft estate, S3 data gravity and SQL analysis to point a genomics group to Azure, AWS or Google Cloud.](/article-images/illustrations/aws-vs-google-cloud-vs-azure-for-genomics-platform-choice.webp) The "when to use AWS" question deserves a direct answer, since AWS is the default choice in cloud bioinformatics and defaults deserve scrutiny. **Use AWS when:** - Your data or collaborators are already in S3, which is common in genomics given the concentration of public datasets there. - You need the deepest pool of genomics-specific tooling, published pipelines, and community knowledge. The ecosystem maturity advantage documented for AWS extends across its service catalog. - Your workload is large, bursty, and fault-tolerant, because AWS's spot market is the most liquid of the three, meaning more capacity is available at interruptible prices when you fan out thousands of tasks. - You want maximum hiring leverage. More bioinformaticians have production AWS experience than Azure experience. **Prefer a competitor when:** - Your analytic center of gravity is SQL over variant tables, where BigQuery's model is genuinely pleasant, and your data is not already trapped elsewhere. - Your institution's compliance and identity infrastructure is Microsoft-based, where Azure's integration advantages dominate [4][6]. - You have an enterprise agreement with one provider that materially changes effective pricing, since agreements can outweigh list-price differences [3]. ## Common Mistakes and Limitations These are the errors that cost genomics teams real money and months of time. 1. **Benchmarking with toy workloads.** A "hello world" WGS run on one sample tells you almost nothing. Benchmark your actual pipeline on representative samples, on at least two instance families per cloud, and include the cost of failed spot interruptions in the calculation. 2. **Ignoring egress until month six.** Teams choose a cloud, upload 200 TB, then discover their downstream consumers need it elsewhere. Model data movement before committing. Pricing comparisons emphasize that effective cross-cloud cost comparison is structurally difficult, and hidden fees are a documented failure mode [3]. 3. **Running everything on-demand.** On-demand pricing for steady workloads is the most expensive configuration on all three clouds. Reserved or committed capacity for baseline load and spot for burst load is the standard pattern, and studies document double-digit percentage savings from disciplined model selection [3]. 4. **Letting scratch data accumulate.** Genomics pipelines generate enormous intermediate files. Every temporary BAM left in a bucket is a recurring charge. Build deletion into the pipeline, not into a quarterly cleanup cron job someone will eventually disable. 5. **Assuming managed [genomics services](/blog/guides/genomics-services) remove all operational skill requirements.** The managed surfaces reduce plumbing, not thinking. Someone on the team still needs to understand the pipeline, the cost drivers, and the failure modes. 6. **Choosing a cloud before choosing a workflow engine.** Pick Nextflow, WDL, or Snakemake first, write the pipeline portably in containers, and the cloud decision becomes reversible. Do the reverse and you have coupled your science to a vendor. 7. **Treating multi-cloud as free optionality.** Operating on two clouds roughly doubles the security, identity, and operational surface, and the interoperability literature documents real friction from divergent APIs and identity models [14][16]. Multi-cloud should be a requirement forced by external constraints, not a hedge adopted casually. 8. **Overestimating the durability of any single comparison.** All three providers iterate rapidly, and a study finding from one year may not hold the next. The benchmarking literature itself cautions that the optimal choice is application-specific and time-sensitive. One limitation applies to the comparison itself. The published head-to-head studies of these platforms examine general cloud workloads, high-performance computing, machine learning services, and pricing models, not genomics pipelines specifically. Findings from those studies transfer because [genomics jobs](/blog/careers/genomics-jobs) are ordinary containers, storage, and batch compute, but a team making a high-stakes platform commitment should still run its own evaluation on its own pipeline. ## Frequently Asked Questions ### Which cloud is cheapest for genomics workloads? No cloud is universally cheapest. Cost depends far more on which pricing model you select per workload than on provider list prices, and studies across AWS, Azure, and Google Cloud show that deliberate optimization strategies can reduce costs by roughly 15 to 67 percent on any platform [3][4]. Benchmark your pipeline, use spot capacity for scatter tasks, commit to reserved capacity for baseline load, and tier old data to archive storage. ### For genomics specifically, is AWS or Google Cloud the better choice? AWS or Google Cloud both handle genomics pipelines well, so the choice usually turns on data gravity and team skills rather than capability. AWS has the deepest genomics ecosystem and the largest concentration of public reference data in S3 [4][1], while Google Cloud is strong for AI-optimized workloads and SQL-style analysis of variant data in BigQuery [4]. If your data and collaborators live in one cloud already, start there. ### Can I run the same Nextflow pipeline on AWS, Google Cloud, and Azure? Yes. Nextflow, WDL with Cromwell, and Snakemake all support AWS Batch, Google Batch, and Azure Batch execution backends, and container-based workloads are the most portable mechanism across the three clouds [14]. Keep your pipeline containerized and tool-agnostic and switching clouds is an infrastructure task rather than a rewrite. ### Which platform should a clinical genomics laboratory choose? Clinical labs inside Microsoft-based hospital systems usually benefit most from Azure, which comparative studies identify as strongest in enterprise integration and compliance services [4]. Governance-focused research suggests that operationalizing MLOps and trustworthy analytics under frameworks like the NIST AI Risk Management Framework matters more than the provider label for regulated deployments [6]. Match the platform to your institution's existing compliance infrastructure. ### Is a multi-cloud strategy worth it for a genomics group? Usually no, unless external constraints force it. Multi-cloud adoption is growing for vendor independence, but it introduces real interoperability friction from divergent APIs, identity models, and tooling [14][16], and it multiplies your security and cost-management surface across platforms with different vulnerability profiles [13]. Standardize on one cloud when you can, and keep your pipelines portable so you retain the option to leave. ### When should I use AWS instead of building my own HPC cluster? Use AWS when your demand is bursty, when you need more capacity than your cluster has during scatter phases, or when capital purchases and cluster administration cost more than cloud premiums. The spot market and autoscaling pattern are well suited to the fault-tolerant, embarrassingly parallel structure of genomics secondary analysis [3]. Keep an on-premises or hybrid footprint when you have steady, predictable load, existing funded hardware, or data governance rules that keep certain data off public clouds. ## Sources 1. [Cloud Computing: Comparison and Analysis of Cloud Service Providers-AWs, Microsoft and Google](https://doi.org/10.1109/SMART50582.2020.9337100) 2. [Decoding the Cloud Giants: A Comparison of AWS, Azure and GCP](https://doi.org/10.48175/ijarsct-18904) 3. [Comparative Evaluation of Cloud Pricing Models: Insights from Aws, Microsoft Azure, and GCP](https://doi.org/10.32628/ijsrst2512368) 4. [Optimizing MLaaS Platform Selection: A Performance, Cost, and Security Analysis of AWS, Google Cloud, and Microsoft Azure](https://doi.org/10.1109/MIPRO70003.2026.11591983) 5. [The Impact of Cloud Computing on Data Engineering: Leveraging AWS, Google Cloud, and Azure](https://doi.org/10.63282/3050-9246.ijetcsit-v4i3p118) 6. [Governed Cloud AI for Financial Services: MLOps, Foundation Models, and Trustworthy AI Analytics across AWS, Azure, and Google Cloud](https://doi.org/10.63646/jaiaa.2024.020204) 7. [Comparison of Microsoft Azure, Google Cloud, and Amazon Web Services for High-Performance Computing](https://doi.org/10.1109/ICITDA64560.2024.10809404) 8. [Evaluating Cloud Platforms for Real-Time Cooperative Perception Systems Using RSU Cameras: A Comparative Study of Google Colab, Azure, and AWS](https://doi.org/10.4271/2026-01-0018) 9. [A Comparative Analysis of Resource Management and Cost Efficiency in AWS, Google Cloud and Microsoft Azure](https://doi.org/10.15680/ijirset.2025.1402008) 10. [Comparative Security and Compliance Analysis of Serverless Computing Platforms: AWS Lambda, Azure Functions, and Google Cloud Functions](https://doi.org/10.55041/ijsrem36979) 11. [The Role of Artificial Intelligence and Machine Learning Services in AWS, Google Cloud, and Azure](https://doi.org/10.36948/ijfmr.2025.v07i02.40602) 12. [PREDICTIVE SQL INJECTION DETECTION AND PREVENTION USING MACHINE LEARNING ACROSS AWS, AZURE, AND GOOGLE CLOUD PLATFORMS](https://doi.org/10.64771/ijesat.2022.v22.i08.pp68-74) 13. [Cross-Cloud Vulnerability Severity Prediction: A Comparative Machine Learning Analysis of AWS, Azure, and Google Cloud Platform Dataset](https://doi.org/10.1109/IDCIoT67589.2026.11455782) 14. [Multi-Cloud Interoperability: Integrating Microsoft Azure with AWS and Google Cloud](https://doi.org/10.61424/ijans.v2i2.1075) 15. [Comparative Analysis of Sustainability, Carbon Footprint, and AI's Role in Reducing Emissions Across AWS, Azure, and Google Cloud](https://doi.org/10.55041/ijsrem37115) 16. [Implementing Multi-Cloud Strategies with Azure, Amazon Web Services (AWS), and Google Cloud for Enhanced Business Continuity](https://doi.org/10.71097/ijsat.v15.i2.1647)